Using blood tests to predict diabetic kidney disease progression
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether two simple blood tests (a measure of insulin resistance and certain inflammation markers) can help predict how diabetic kidney disease will progress. If you have diabetes and early kidney problems, this might help your doctor better understand your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with type 1 or type 2 diabetes.
- You must be willing to give informed consent and have blood drawn for lab tests.
- You must not have kidney problems from causes other than diabetes.
- You must not have acute kidney injury or an active infection/inflammation.
- You must not be on dialysis or have had a kidney transplant.
- You must not have other conditions that affect blood sugar, fats, or blood cells (such as uncontrolled thyroid disease, active cancer, blood disorders, or current use of certain medications).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to find early signs of kidney damage in people with diabetes. The goal is to catch kidney disease (diabetic nephropathy) sooner, so it can be managed more effectively.
This study is looking at whether certain markers of inflammation in the blood can help detect or monitor kidney damage caused by type 2 diabetes. It compares these new markers with a well-known one (MCP-1) to see which might be more helpful for patients.
This study checks whether a set of blood and urine tests can predict “acute kidney injury” (a sudden worsening of kidney function) earlier in people with diabetes who are undergoing a heart procedure. If the tests work, they may help doctors spot kidney trouble sooner and protect your kidneys.
This trial tests a new system to manage diabetic kidney disease across all stages. It is for people with type 2 diabetes who either have no kidney damage or have kidney damage confirmed by a biopsy.
This study looks at simple blood tests to see if certain markers of inflammation and platelet levels are different in people with diabetic kidney disease compared to healthy people. The results might help doctors find kidney problems earlier in people with type 2 diabetes.
This study looks at how the bacteria in your gut and certain blood markers might help predict changes in blood sugar levels for people with type 2 diabetes and kidney disease. The findings could lead to better ways to manage your condition and prevent complications.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.